鳥居薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/05/01 | 2,900 | 2,972 | 2,888 | 2,960 | -16 | -0.5% | 62,000 |
2020/04/30 | 3,000 | 3,015 | 2,943 | 2,976 | +4 | +0.1% | 48,400 |
2020/04/28 | 2,980 | 2,980 | 2,900 | 2,972 | +8 | +0.3% | 24,700 |
2020/04/27 | 2,974 | 2,975 | 2,933 | 2,964 | -10 | -0.3% | 28,100 |
2020/04/24 | 2,999 | 2,999 | 2,949 | 2,974 | -8 | -0.3% | 25,100 |
2020/04/23 | 3,045 | 3,045 | 2,947 | 2,982 | +21 | +0.7% | 44,200 |
2020/04/22 | 2,940 | 2,992 | 2,914 | 2,961 | +21 | +0.7% | 43,400 |
2020/04/21 | 2,925 | 2,985 | 2,919 | 2,940 | -35 | -1.2% | 31,200 |
2020/04/20 | 2,950 | 2,989 | 2,947 | 2,975 | +9 | +0.3% | 33,600 |
2020/04/17 | 3,040 | 3,040 | 2,962 | 2,966 | -33 | -1.1% | 39,500 |
2020/04/16 | 2,940 | 3,040 | 2,927 | 2,999 | +62 | +2.1% | 48,300 |
2020/04/15 | 2,954 | 2,968 | 2,883 | 2,937 | -40 | -1.3% | 76,200 |
2020/04/14 | 2,905 | 3,070 | 2,905 | 2,977 | +122 | +4.3% | 111,500 |
2020/04/13 | 2,803 | 2,891 | 2,782 | 2,855 | +102 | +3.7% | 62,300 |
2020/04/10 | 2,700 | 2,772 | 2,684 | 2,753 | +119 | +4.5% | 54,100 |
2020/04/09 | 2,570 | 2,657 | 2,528 | 2,634 | +90 | +3.5% | 70,800 |
2020/04/08 | 2,563 | 2,601 | 2,468 | 2,544 | -19 | -0.7% | 60,200 |
2020/04/07 | 2,632 | 2,635 | 2,506 | 2,563 | -19 | -0.7% | 41,600 |
2020/04/06 | 2,490 | 2,585 | 2,465 | 2,582 | +57 | +2.3% | 33,900 |
2020/04/03 | 2,543 | 2,618 | 2,506 | 2,525 | -10 | -0.4% | 24,400 |
2020/04/02 | 2,573 | 2,600 | 2,506 | 2,535 | -53 | -2% | 42,700 |
2020/04/01 | 2,695 | 2,695 | 2,563 | 2,588 | -111 | -4.1% | 44,300 |
2020/03/31 | 2,685 | 2,751 | 2,651 | 2,699 | -11 | -0.4% | 80,300 |
2020/03/30 | 2,766 | 2,766 | 2,620 | 2,710 | +94 | +3.6% | 90,900 |
2020/03/27 | 2,480 | 2,616 | 2,430 | 2,616 | +135 | +5.4% | 91,300 |
2020/03/26 | 2,485 | 2,502 | 2,354 | 2,481 | -20 | -0.8% | 70,100 |
2020/03/25 | 2,448 | 2,501 | 2,390 | 2,501 | +153 | +6.5% | 99,100 |
2020/03/24 | 2,375 | 2,424 | 2,295 | 2,348 | +84 | +3.7% | 118,200 |
2020/03/23 | 2,249 | 2,321 | 2,129 | 2,264 | +64 | +2.9% | 120,600 |
2020/03/19 | 2,463 | 2,498 | 2,169 | 2,200 | -213 | -8.8% | 157,400 |
2020/03/18 | 2,490 | 2,560 | 2,378 | 2,413 | -14 | -0.6% | 120,600 |
2020/03/17 | 2,363 | 2,486 | 2,309 | 2,427 | ±0 | ±0% | 98,400 |
2020/03/16 | 2,489 | 2,567 | 2,410 | 2,427 | +38 | +1.6% | 69,400 |
2020/03/13 | 2,258 | 2,422 | 2,212 | 2,389 | -219 | -8.4% | 125,400 |
2020/03/12 | 2,713 | 2,760 | 2,608 | 2,608 | -205 | -7.3% | 69,600 |
2020/03/11 | 2,859 | 2,911 | 2,807 | 2,813 | -31 | -1.1% | 53,800 |
2020/03/10 | 2,688 | 2,849 | 2,678 | 2,844 | -15 | -0.5% | 68,700 |
2020/03/09 | 2,985 | 3,020 | 2,849 | 2,859 | -196 | -6.4% | 43,400 |
2020/03/06 | 3,070 | 3,135 | 3,045 | 3,055 | -75 | -2.4% | 52,000 |
2020/03/05 | 3,160 | 3,180 | 3,120 | 3,130 | +20 | +0.6% | 28,700 |
2020/03/04 | 3,085 | 3,135 | 3,060 | 3,110 | -35 | -1.1% | 58,700 |
2020/03/03 | 3,340 | 3,340 | 3,145 | 3,145 | -130 | -4% | 62,100 |
2020/03/02 | 3,155 | 3,305 | 3,145 | 3,275 | +50 | +1.6% | 51,500 |
2020/02/28 | 3,415 | 3,415 | 3,200 | 3,225 | -260 | -7.5% | 91,100 |
2020/02/27 | 3,455 | 3,505 | 3,445 | 3,485 | +40 | +1.2% | 70,900 |
2020/02/26 | 3,490 | 3,525 | 3,440 | 3,445 | -80 | -2.3% | 66,800 |
2020/02/25 | 3,515 | 3,595 | 3,490 | 3,525 | -100 | -2.8% | 59,500 |
2020/02/21 | 3,580 | 3,630 | 3,580 | 3,625 | +20 | +0.6% | 29,000 |
2020/02/20 | 3,645 | 3,645 | 3,580 | 3,605 | -10 | -0.3% | 31,400 |
2020/02/19 | 3,580 | 3,655 | 3,580 | 3,615 | +50 | +1.4% | 54,100 |
1301~
1350
件表示中 / 3769件
類似銘柄と比較する
現在ご覧いただいている「鳥居薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.45倍 |
|
JT傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がTOB実施 |
ペプチド | 154,000円 | +5.0% | +1.5% | 0.00% | 13.18倍 | 3.71倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
キッセイ薬 | 426,500円 | +3.6% | - | 2.81% | 14.37倍 | 0.85倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
サンバイオ | 239,600円 | - | - | 0.00% | - | 110.98倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
科研薬 | 385,500円 | -6.4% | -71.8% | 4.93% | 42.93倍 | 0.96倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
市場注目の銘柄
チャート関連のコラム